Torsten Fahrig
Directeur Financier/CFO chez RESprotect GmbH
Provenance du réseau au premier degré de Torsten Fahrig
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
RESprotect GmbH
 RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany.
9
| Holding Company | Pharmaceuticals: Other | 9 |
UroTiss GmbH
 UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany.
3
| Subsidiary | Medical/Nursing Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Torsten Fahrig via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree Undergraduate Degree | |
| California State University-Los Angeles | College/University | Corporate Officer/Principal | |
| PROPANC BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Bonn | College/University | Corporate Officer/Principal |
Statistiques
Internationale
| Allemagne | 3 |
| Etats-Unis | 2 |
| Australie | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
Opérationnelle
| Corporate Officer/Principal | 7 |
| Chief Tech/Sci/R&D Officer | 4 |
| Chief Executive Officer | 3 |
| Founder | 3 |
| President | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Torsten Fahrig
- Connexions Sociétés
